Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 24, 2017
Pharmacy Choice - Pharmaceutical News - Credence Research: Opioid Induced Constipation Drugs Market Size, Share, Growth, Strategies and Forecast 2017 2025 - November 24, 2017

Pharmacy News Article

 5/17/17 - Credence Research: Opioid Induced Constipation Drugs Market Size, Share, Growth, Strategies and Forecast 2017 2025

According to a recently published report by Brisk Insights, the Global Opioid Induced Constipation (OIC) Drugs Market is expected to grow at the CAGR of 4.6% during 2017-2025. The global opioid induced constipation drugs market is segmented on the basis of drug type, prescription type and geography. The report on global opioid induced constipation drugs market (by drug type, prescription type and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Opioid Induced Constipation (OIC) Drugs Market: Global Industry Size, Growth, Share and Forecast to 2025 report at

Market Insights

The global opioid induced constipation (OIC) drugs market is anticipated to grow significantly during the forecast period due to rising opioid prescription for non-cancer pain in the previous decade. It is observed that Methylnaltrexone bromide, lubiprostone and naloxegol drugs are widely accepted in market for treatment of OIC. Among these, methylnaltrexone bromide currently held largest market share and is expected to show significant growth during the forecast period because it provides good relief from constipation in terminally ill patients who do not respond to laxatives. Currently, Naloxegol is widely accepted OIC drugs for the treatment of constipation and is expected to grow at highest CAGR during forecast period due it relieve constipation without reducing the pain relieving effects of opioids is the major factor would fuel the growth of Naloxegol market during forecast period. Promising pipeline molecules such as Naldemedine, Elobixibat and Dolcanatide expected to drive the growth of OIC drugs market during forecast period. Currently, North America and Europe is expected to be the largest regional market for OIC drugs worldwide due to higher cost of treatment, upsurge in funding by government and adoption of novel medication are influencing the growth of OIC drugs market in North America and Europe.

Browse here for all category Reports :

Scope of the report

1. Global OIC Drugs Market, by Drug Type, 2015 - 2025 ($ Million)

1.1. Methylnaltrexone Bromide

1.2. Lubiprostone

1.3. Naloxegol

1.4. Pipeline Drug Analysis: Naldemedine, Elobixibat and Dolcanatide

2. Global OIC Drugs Market, by Prescription Type, 2015 - 2025 ($ Million)

2.1. Prescribed Drugs

2.2. Over the Counter Drugs

3. Global OIC Drugs Market, by Geography, 2015-2025 ($ Million)

3.1. North America

3.1.1. U.S.

3.1.2. Canada

3.2. Europe

3.2.1. U.K.

3.2.2. Germany

3.2.3. France

3.2.4. Rest of Europe

3.3. Asia Pacific

3.3.1. Japan

3.3.2. China

3.3.3. Rest of Asia Pacific

3.4. Latin America (LATAM)

3.4.1. Brazil

3.4.2. Mexico

3.4.3. Rest of Latin America

3.5. Middle East and Africa (MEA)

4. Company Profiles

4.1. Astrazenenca

4.2. Cubist Pharmaceuticals (Adolor Corporation)

4.3. Daiichi Sankyo Co. Ltd.

4.4. Ironwood Pharmaceuticals, Inc.

4.5. Pfizer

4.6. Progenics Pharmaceuticals Inc

4.7. Salix Pharmaceuticals Ltd

4.8. Shionogo & Co Ltd

4.9. Sucampo Pharmaceuticals

4.10. Synergy Pharmaceuticals Inc.

Download Free Request Sample :

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.

Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

CONTACT: Contact Us :

Jennifer Smith

Office 1094

109 Vernon House

Friar Lane



United Kingdom

Phone : +448081890034 (UK)

Email :

Website :



Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Nov 29: Influenza 2017-2018: An Update on Prevention and Treatment
Nov 30: School is Out! Life is in Session: The Importance of Professional Development in Pharmacy
Dec 01: Anticoagulants: The Rapidly Changing Landscape
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement